Skip to content
On this page:OverviewPublicationsResearchersInstitutionsOpen access
PICO Portalanswers from OpenAlex

Vifor Pharma (Switzerland)

InstitutionResearch output, impact & collaborations

Vifor Pharma (Switzerland) is a institution indexed in PICO Portal from OpenAlex.

What is known about Vifor Pharma (Switzerland)?

PICO Portalrecord summary

Vifor Pharma (Switzerland) is a research organisation in Glattbrugg, CH. OpenAlex records 964 works and 58,702 citations for it. 245 researchers list it as their most recent affiliation.

How many works does Vifor Pharma (Switzerland) have?

PICO Portalindexed works

Vifor Pharma (Switzerland) has 964 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Vifor Pharma (Switzerland) have?

PICO Portalcitation count

Vifor Pharma (Switzerland) has 58,702 citations in the OpenAlex counts PICO Portal stores.

How many researchers are at Vifor Pharma (Switzerland)?

PICO Portalresearcher count

Vifor Pharma (Switzerland) has 245 researchers in the PICO Portal index.

What is the average h-index at Vifor Pharma (Switzerland)?

PICO Portalavg h-index

Vifor Pharma (Switzerland) has an average h-index of 15 in OpenAlex.

What is the ROR of Vifor Pharma (Switzerland)?

PICO Portalror

The ROR for Vifor Pharma (Switzerland) is on the source record.

What is the OpenAlex record for Vifor Pharma (Switzerland)?

PICO Portalopenalex

The OpenAlex for Vifor Pharma (Switzerland) is on the source record.

Who are the most-cited researchers behind Vifor Pharma (Switzerland)?

PICO Portaltop researchers by citations
1
Antonio Ramírez de Arellano · Diabetes Management and Research
64 works492 citations

What are the most-cited papers on Vifor Pharma (Switzerland)?

PICO Portalmost cited works
The Economic Burden of Insulin-Related Hypoglycemia in Spain
Witesh Parekh, Nicki Hoskins, James Baker‐Knight, Antonio Ramírez de Arellano, Pedro Mezquita Raya
Diabetes Therapy. 201734 CitationsOPEN ACCESS
The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland
Thomas Ward, Tray Brown, Ruth D. Lewis, Melodi Koşaner Kließ, Antonio Ramírez de Arellano, Carol Moreno Quinn
PharmacoEconomics - Open. 202232 CitationsOPEN ACCESS
Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising <scp>AFFIRM‐AHF</scp>
Phil McEwan, Piotr Ponikowski, Jason A. Davis, Giuseppe Rosano, Andrew J.S. Coats, Fabio Dorigotti, Donal O'Sullivan, Antonio Ramírez de Arellano, Ewa A. Jankowska
European Journal of Heart Failure. 202131 CitationsOPEN ACCESS
Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin
Antonio Pérez, Pedro Mezquita Raya, Antonio Ramírez de Arellano, Teresa Briones, Barnaby Hunt, William J. Valentine
Diabetes Therapy. 201530 CitationsOPEN ACCESS
Self-Reported Frequency and Impact of Hypoglycemic Events in Spain
Domingo Orozco‐Beltrán, Pedro Mezquita‐Raya, Antonio Ramírez de Arellano, Manuel Galán
Diabetes Therapy. 201430 CitationsOPEN ACCESS

How much of the research on Vifor Pharma (Switzerland) is open access?

PICO Portalopen access share
100%OPEN ACCESS
Gold
73%
Green
0%
Hybrid
18%
Bronze
9%
Closed
0%

Related on PICO Portal

470M+ articles · 14-day free trial